LONDON, March 13, 2025 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company focused on the detection of immune responses and ...

On Thursday, Virax Biolabs Group Limited (NASDAQ:VRAX) said it supports the U.S. Department of Health and Human Services’ focus on vaccine efficacy transparency, emphasizing the need for ...

LONDON - Virax Biolabs Group Limited (NASDAQ:VRAX), a micro-cap biotechnology company with a market value of $6.39 million specializing in immune response detection and viral disease diagnosis ...

Virax Biolabs' technology supports vaccine efficacy assessments and long-term immune protection monitoring. The company collaborates with vaccine developers to enhance transparency and advance ...

LONDON - Virax Biolabs Group Limited (NASDAQ:VRAX), a micro-cap biotechnology company with a market value of $6.39 million specializing in immune response detection and viral disease diagnosis, has ...

An institutional investor recently bought a new position in Virax Biolabs Group stock. XTX Topco Ltd purchased a new position in shares of Virax Biolabs Group Limited (NASDAQ:VRAX – Free Report ...

Hartzell Propeller has unveiled a new lightweight carbon fiber constant speed prop specifically designed for Rotax 916 powered aircraft, it announced Tuesday. CubCrafters’ Carbon Cub UL is the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...